Quinolone antibiotic with potential to photosensitize skin tumorigenesis

Journal of Photochemistry and Photobiology B: Biology

Volumn 37, Issue 3, 1997, Pages 171-173

  Johnson, Brian E ^a   Gibbs, Neil K ^a   Ferguson, James ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLEROXACIN; PHOTOSENSITIZING AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PHOTOSENSITIZATION; PRIORITY JOURNAL; SKIN CARCINOGENESIS;

ANIMALS; ANTI-INFECTIVE AGENTS; DERMATITIS, PHOTOTOXIC; FLEROXACIN; MICE; NEOPLASMS, RADIATION-INDUCED; RADIATION-SENSITIZING AGENTS; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 0031081805     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(96)07423-4     Document Type: Article

References (18)

1. [1] F. Urbach, Photocarcinogenesis, in J.D́. Regan and J.A. Parrish (eds.), The Science of Photomedicine, Plenum, New York, 1982, pp. 261-292.
2. [2] L.C. Harber, I.E. Kochevar and A.R. Shalita, Mechanisms of photosensitization to drugs in humans, in J.D. Regan and J.A. Parrish (eds.), The Science of Photomedicine, Plenum, New York, 1982, pp. 323-347.
3. [3] B.E. Johnson and J. Ferguson, Drug and chemical photosensitivity, Sem. Dermatol., 9 (1990) 39-46.
4. [4] J.A. Parrish, T.B. Fitzpatrick, L. Tanenbaum and M.A. Pathak, Photochemotherapy of psoriasis with oral methoxalen and longwave ultraviolet light, N. Engl. J. Med., 291 (1974) 1207-1211.
5. [5] A.R. Young, I.A. Magnus, A.C. Davis and N.P. Smith, A comparison of the phototumorigenic potential of 8-MOP and 5-MOP in hairless albino mice exposed to solar simulated radiation, Br. J. Dermatol., 108 (1983) 507-518.
6. [6] N.K. Gibbs, A.R. Young and I.A. Magnus, Failure of UVR dose reciprocity for skin tumorigenesis in hairless mice treated with 8-methoxypsoralen, Photochem. Photobiol., 42 (1985) 39-42.
7. [7] R.S. Stern, N. Laird and J. Melski et al., Cutaneous squamous-cell carcinoma in patients treated with PUVA, N. Engl. J. Med., 310 (1984) 1156-1161.
8. [8] R.S. Ster and N. Laird, The carcinogenic risk of treatments for severe psoriasis, Cancer, 73 (1994) 2759-2764.
9. [9] F. Zajdela and E. Bisagni, 5-methoxypsolaren, the melangenic additive in sun-tan preparations in tumorigenic in mice exposes to 365 nm u.v. radiation, Carcinogenesis, 2 (1985) 121-128.
10. [10] G.E. Kelly, W.D. Meikle and D.E. Moore, Enhancement of UV-induced skin carcinogenesis by azathioprine: role of photochemical sensitization, Photochem. Photobiol., 49 (1989) 59-65.
11. [11] C.A. Ramsay and E. Obreshkova, Photosensitivity from nalidixic acid, Br. J. Dermatol., 91 (1974) 523-528.
12. [12] J. Ferguson, Fluoroquinolone photosensitization: a review of clinical and laboratory studies, Photochem. Photobiol., (1995) 954-958.
13. [13] J. Ferguson and B.E. Johnson, Clinical and laboratory studies of the photosensitizing potential of norfloxacin, a 4-quinolone broad-spectrum antibiotic, Br. J. Dermatol., 128 (1992) 285-295.
14. [14] J.T. Keane, R.W. Pearson and F.D. Malkinson, Nalidixic acid-induced photosensitivity in mice: a model for pseudo porphyria, J. Invest. Dermatol., 82 (1984) 210-213.
15. [15] T. Hus, P.D. Forbes, L.C. Harber and E. Lakow, Induction of skin tumors in hairless mice following single exposure to ultraviolet radiation, Photochem. Photobiol., 21 (1975) 185-188.
16. [16] F.R. de Gruijl, H.J.C.M. Sterenbourg, P.D. Forbes, R.E. Davies, C. Cole, G. Kelfkens, H. van Weelden, H. Slaper and J.C. van der Leun, Wavelength dependence of skin cancer induction by ultraviolet irradiation of albino hairless mice, Cancer Res., 53 (1993) 53-60.
17. [17] Anonymous, FDA committee urges stronger warnings on Maxaquin (editorial), SCRIPT, 1810 (1993) 32-33.
18. [18] G. Klecak, F. Urbach and H. Urwyler, Fluoroquinolone antibacterials enhance UVA-induced skin tumors, J. Photochem. Photobiol. B: Biol., 37 (1991) 174-181.